|
An activating 1849G>T mutation of JAK2 tyrosine kinase was recently
described in chronic myeloproliferative disorders (MPD). Its role in other
hematological neoplasms is unclear. We developed a quantitative pyrosequencing
assay and analyzed 374 samples of hematological neoplasms. The mutation was
frequent in polycythemia vera (PV) (86%) and myelofibrosis (95%) but less
prevalent in acute myeloid leukemia (AML) with an antecedent PV or myelofibrosis
(5/14 patients or 36%).
New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: [email protected] Subscribe: [EMAIL PROTECTED] Unsubscribe: [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED] CML Group Web Site http://groups.yahoo.com/group/CML YAHOO! GROUPS LINKS
|
